David A. Keays

1.9k citations

20 papers · 726 indexed · h-index 14

Co-authors: Ken R. Gayler Bruce G. Livett David Sandall Zeinab G. Khalil Taane G. Clark Jonathan Flint John Down Vi Pham
Topics: Nicotinic Acetylcholine Receptors Study (4 papers)Cellular transport and secretion (3 papers)Microtubule and mitosis dynamics (3 papers)
Cited by: Molecular Biology Cell Biology Genetics
Journals: Biochemistry Neuroscience Human Molecular Genetics
Partner nations: United Kingdom Austria Australia

In The Last Decade

David A. Keays

20 papers receiving 708 citations

Peers

Countries citing papers authored by David A. Keays

Since Specialization

Citations

This map shows the geographic impact of David A. Keays's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Keays with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Keays more than expected).

Fields of papers citing papers by David A. Keays

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Keays. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Keays. The network helps show where David A. Keays may publish in the future.

Co-authorship network of co-authors of David A. Keays

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Keays. A scholar is included among the top collaborators of David A. Keays based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Keays. David A. Keays is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	MAPping tubulin mutations 2023 ·Frontiers in Cell and Developmental Biology ·Thomas D. Cushion,(unknown),David A. Keays	9
2	De Novo Mutations in DENR Disrupt Neuronal Development and Link Congenital Neurological Disorders to Faulty mRNA Translation Re-initiation 2016 ·Cell Reports ·Matilda Haas,Linh Ngo,Shanshan Li,Sibylle Schleich,Zhengdong Qu,Hannah Vanyai,(unknown),(unknown),Ivan Gladwyn‐Ng,Alistair T. Pagnamenta,Jenny C. Taylor,Helen Stewart,Usha Kini,Kent E. Duncan,Aurelio A. Teleman,David A. Keays,Julian Ik‐Tsen Heng	26
3	Activation of an exonic splice‐donor site in exon 30 of CDK5RAP2 in a patient with severe microcephaly and pigmentary abnormalities 2016 ·Clinical Case Reports ·Alistair T. Pagnamenta,Malcolm F. Howard,Samantha J.L. Knight,David A. Keays,Gerardine Quaghebeur,Jenny C. Taylor,Usha Kini	9
4	Deletions and de novo mutations of SOX11 are associated with a neurodevelopmental disorder with features of Coffin–Siris syndrome 2015 ·Journal of Medical Genetics ·(unknown),Alistair T. Pagnamenta,Moira Blyth,Sahar Mansour,Vivienne McConnell,Ikuyo Kou,Shiro Ikegawa,Yoshinori Tsurusaki,Naomichi Matsumoto,Adriana Lo‐Castro,Ghislaine Plessis,Beate Albrecht,Agatino Battaglia,Jenny C. Taylor,Malcolm F. Howard,David A. Keays,(unknown),Susanne J. Kühl,Usha Kini,Alisdair McNeill	53
5	A novel nonsense CDK5RAP2 mutation in a Somali child with primary microcephaly and sensorineural hearing loss 2012 ·American Journal of Medical Genetics Part A ·Alistair T. Pagnamenta,Jennie Murray,Grace Yoon,Elham Sadighi Akha,Victoria Harrison,Louise S. Bicknell,(unknown),Helen Stewart,Usha Kini,Jenny C. Taylor,David A. Keays,Andrew P. Jackson,Samantha J.L. Knight	33
6	Exome sequencing can detect pathogenic mosaic mutations present at low allele frequencies 2011 ·Journal of Human Genetics ·Alistair T. Pagnamenta,Stefano Lise,Victoria Harrison,Helen Stewart,Sandeep Jayawant,Gerardine Quaghebeur,(unknown),(unknown),Elham Sadighi Akha,Andy Rimmer,Iain Mathieson,Samantha J.L. Knight,Usha Kini,Jenny C. Taylor,David A. Keays	46
7	Cytoarchitectural disruption of the superior colliculus and an enlarged acoustic startle response in the Tuba1a mutant mouse 2011 ·Neuroscience ·Andrew Edwards,Christoph D. Treiber,Martin W. Breuss,Ruth Pidsley,Guo‐Jen Huang,James Cleak,Peter L. Oliver,Jonathan Flint,David A. Keays	5
8	Disease-associated mutations in TUBA1A result in a spectrum of defects in the tubulin folding and heterodimer assembly pathway 2010 ·Human Molecular Genetics ·Guoling Tian,Xavier H. Jaglin,David A. Keays,Fiona Francis,Jamel Chelly,Nicholas J. Cowan	47
9	Behavioural characterisation of the robotic mouse mutant 2007 ·Behavioural Brain Research ·Peter L. Oliver,David A. Keays,Kay E. Davies	17
10	Neuronal migration: unraveling the molecular pathway with humans, mice, and a fungus 2007 ·Mammalian Genome ·David A. Keays	13
11	Estimating the number of coding mutations in genotypic and phenotypic driven N-ethyl-N-nitrosourea (ENU) screens: revisited 2007 ·Mammalian Genome ·David A. Keays,Taane G. Clark,Thomas G. Campbell,John Broxholme,William Valdar	56
12	Estimating the number of coding mutations in genotypic- and phenotypic-driven N-ethyl-N-nitrosourea (ENU) screens 2006 ·Mammalian Genome ·David A. Keays,Taane G. Clark,Jonathan Flint	45
13	Therapeutic applications of conotoxins that target the neuronal nicotinic acetylcholine receptor 2006 ·Toxicon ·Bruce G. Livett,David Sandall,David A. Keays,John Down,Ken R. Gayler,(unknown),Zeinab G. Khalil	105
14	Molecular prospecting for drugs from the sea 2005 ·IEEE Engineering in Medicine and Biology Magazine ·Ken R. Gayler,David Sandall,David W. Greening,David A. Keays,(unknown),Bruce G. Livett,John Down,(unknown),Zeinab G. Khalil	13
15	New semidominant mutations that affect mouse development 2004 ·genesis ·Debora Bogani,Nick Warr,(unknown),Jennifer R. Davies,Zuzanna Tymowska‐Lalanne,Michelle Goldsworthy,Roger Cox,David A. Keays,Jonathan Flint,Valerie Wilson,Patrick M. Nolan,Ruth M. Arkell	22
16	Determining sequences and post‐translational modifications of novel conotoxins in Conus victoriae using cDNA sequencing and mass spectrometry 2004 ·Journal of Mass Spectrometry ·Jennifer A. Jakubowski,David A. Keays,Wayne P. Kelley,David Sandall,Jon‐Paul Bingham,Bruce G. Livett,Ken R. Gayler,Jonathan V. Sweedler	47
17	N-ethyl-N-nitrosourea mouse mutants in the dissection of behavioural and psychiatric disorders 2003 ·European Journal of Pharmacology ·David A. Keays,Patrick M. Nolan	17
18	A Novel α-Conotoxin Identified by Gene Sequencing Is Active in Suppressing the Vascular Response to Selective Stimulation of Sensory Nerves in Vivo 2003 ·Biochemistry ·David Sandall,(unknown),David A. Keays,(unknown),(unknown),Vi Pham,(unknown),Zeinab G. Khalil,Bruce G. Livett,Ken R. Gayler	152
19	Genetic testing and insurance: When is discrimination justified? 2000 ·Bioethics News ·David A. Keays	4
20	The legal implications of genetic testing: Insurance, employment and privacy 1999 ·Queensland's institutional digital repository (The University of Queensland) ·David A. Keays	7

About David A. Keays

David A. Keays is a scholar working on Aging, Cell Biology and Developmental Neuroscience, having authored 20 papers that have together received 726 indexed citations. Recurring topics across this work include Nicotinic Acetylcholine Receptors Study (4 papers), Cellular transport and secretion (3 papers) and Microtubule and mitosis dynamics (3 papers). The work is most often cited by research in Molecular Biology (589 citations), Cell Biology (95 citations) and Genetics (149 citations). David A. Keays has collaborated with scholars based in United Kingdom, Austria and Australia. Frequent co-authors include Ken R. Gayler, Bruce G. Livett, David Sandall, Zeinab G. Khalil, Taane G. Clark, Jonathan Flint, John Down, Vi Pham, Jenny C. Taylor and Thomas G. Campbell. Their work appears in journals such as Biochemistry, Neuroscience and Human Molecular Genetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact